Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
D86xx56D9x5FRzKW
Listen
